Field guide
Exotic ETFs: a field guide to the weird and wonderful
There are more US-listed ETFs than there are US stocks. Most are sensible index funds. But scroll past those and you reach the zoo: a space fund that trades under the ticker UFO, a cannabis fund called YOLO, a 2x-leveraged fund literally named Animal Spirits. We went hunting through the fund filings for the strangest real ones — and then, because someone has to, worked out how to tell a fun idea from an expensive mistake.
The short version
- There is an ETF for almost everything: space, uranium, pets, Ozempic, social-media hype, the global music business.
- The tickers are half the fun —
UFO,YOLO,HERO,JEDI,BUZZ,MOOD,OZEM,WILD. - They also charge real money: most run 0.5%–1%+ a year versus ~0.05% for a broad index fund. That’s the narrative tax.
- Before buying any of them, check three things: the fee, the size (tiny funds close), and what’s actually inside.
The zoo, by exhibit
Every fund below is real and trades today. We pulled each from the SEC fund filings; the numbers are net assets and expense ratios as filed.
To infinity — the space funds
The most gloriously on-the-nose ticker in the business: UFO, the Procure Space ETF (~$367M), which actually holds satellite and rocket companies. Alongside it, ARK’s ARKX Space Exploration & Innovation ETF (~$821M) and State Street’s Kensho ROKT “Final Frontiers” fund. Space is a genuine industry now; whether it’s a genuine investment at these fees is the open question.
Glow in the dark — uranium and nuclear
The AI-power-demand story revived an entire ETF category. URA (Global X Uranium, ~$6.0B) and NLR (VanEck Uranium & Nuclear, ~$3.6B) are the giants; NUKZ, the Range “Nuclear Renaissance” ETF, is the upstart. These are real, sizeable funds — proof that “exotic” doesn’t always mean tiny.
Sin and YOLO — cannabis
An entire shelf, and the tickers do not disappoint: MSOS (AdvisorShares Pure US Cannabis, ~$921M), YOLO (AdvisorShares Pure Cannabis), WEED (Roundhill Cannabis) and TOKE (Cambria Cannabis). A cautionary tale in one sector: the theme was wildly popular and, for years, a wealth-destroyer. A great story is not a great trade.
Press start — video games and esports
ESPO (VanEck Video Gaming & eSports, ~$369M), HERO (Global X, ~$125M) and the perfectly-named NERD (Roundhill Video Games). If you believe gaming is the dominant entertainment medium, here’s your basket — though most of these hold the same handful of large publishers and chipmakers you may already own.
The Ozempic trade — GLP-1 and obesity
When weight-loss drugs became the biggest story in pharma, the ETFs followed within months: HRTS (Tema GLP-1, Obesity & Cardiometabolic, ~$53M) and OZEM (Roundhill GLP-1 & Weight Loss) — the latter ticker a wink at the drug that started it all. The speed is the lesson: by the time there’s a dedicated ETF, the story is usually well known.
Good boys and animal spirits
PAWZ, the ProShares Pet Care ETF (~$50M), is exactly what it sounds like. And then there’s our favourite name in the whole zoo: WILD, the VistaShares Animal Spirits Daily 2X ETF — a leveraged fund named after Keynes’s phrase for irrational market exuberance. A fund whose name is a literary in-joke about mania is a very 2026 object.
Vibes as a strategy — sentiment funds
Yes, you can buy the vibes. BUZZ (VanEck Social Sentiment ETF, ~$106M) literally picks its holdings from social-media sentiment scores. MOOD (Relative Sentiment Tactical Allocation) and SOCL (Global X Social Media) round out the mood board. Whether crowd sentiment is a signal or a contrarian indicator is, fittingly, a matter of sentiment.
K-pop and the music machine
The one a lot of people ask about. A pure K-pop fund is a niche thing, but the exposure is real and reachable: MUSQ, the Global Music Industry ETF, holds the streaming platforms and the record labels — including the Korean entertainment houses behind the biggest K-pop acts. For the country bet itself there’s EWY (iShares MSCI South Korea, ~$7.0B) and, for the brave, KORU — a 3x-leveraged daily Korea fund (more on why that’s a different animal below).
Drones, defense and the dangerous toys
For the geopolitically inclined: JEDI, the Defiance Drone and Modern Warfare ETF, and KDEF (a Korea Defense Industry fund). And at the far end of the spectrum sit the truly hazardous instruments — leveraged single-stock ETFs. A whole family now offers 2x daily exposure to one company: 2x ASML (ASMG), 2x AMD (AMDG), 2x Boeing (BOEG), 2x MP Materials (MPG). These are not investments. They are stopwatch trades wearing an ETF wrapper.
How to actually read a thematic ETF
The names are delightful; the mechanics are where people lose money. Four checks before you touch any of these.
1. The expense ratio — the narrative tax
A broad S&P 500 fund costs you around 0.03%–0.09% a year. The funds above mostly charge 0.5% to nearly 1%, and the leveraged ones more. That gap is the price of the story, and it compounds against you every single year, in good markets and bad.
2. Assets under management — size is survival
Many exotic ETFs are tiny — some hold only a few million dollars. Small funds have two problems: wide bid-ask spreads (you lose on the way in and out), and closure risk. Funds that don’t gather assets get shut down, often within a couple of years, forcing a taxable exit at the worst time. A fun ticker with $4M in it is a fun ticker, not a durable holding.
3. Leverage decay — the daily-reset trap
The 2x and 3x funds (KORU, WILD, the single-stock family) reset their leverage every day. Over a choppy-but-flat stretch, that daily reset grinds the value down through volatility decay — you can be right about the direction over a month and still lose money. They are built for one-day moves, full stop.
4. Look-through — are you buying what you already own?
Pop the hood on a lot of thematic ETFs and you find the same megacaps. A “next-gen” fund that’s 30% Nvidia, Microsoft and Amazon isn’t giving you new exposure — it’s charging you 0.7% to re-buy your existing portfolio with a better story. Checking holdings overlap before you buy is the single most useful habit here.
The pattern to notice: by the time a theme is famous enough to get its own ETF, the easy money is usually gone. Cannabis, space and social-sentiment funds all launched into enormous enthusiasm and then underperformed. The dedicated ETF is often a top signal, not a starting gun.
Finding them yourself
Every fund here came from one place: the SEC fund filings, queried in plain English. With a markets database connected to an agent over MCP, you can go spelunking too — search funds by theme, filter by fee and size, and check overlap against what you hold:
“Find ETFs about [space / uranium / pets / sentiment]. Show ticker, net assets and expense ratio, sorted by size. Then check how much each one overlaps with the stocks I already own.”
It’s a genuinely fun way to spend ten minutes — and the same screen that surfaces UFO and YOLO also quietly tells you which of them is a $5M fee trap. Once you’ve found a candidate, the discipline is the same as for any holding: size it sensibly and check what it does to your portfolio’s risk before it goes in.
This is entertainment and education, not financial advice. Naming a fund is not endorsing it; the exotic ETFs here range from reasonable niche tools to high-fee novelties to genuinely dangerous leveraged instruments. Fund figures are as filed and change over time. Do your own due diligence, and treat leveraged products with particular caution.